What is the ticker symbol for Opus Genetics?

Opus Genetics trades under the ticker IRD on NASDAQ.

What sector does Opus Genetics operate in?

Opus Genetics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze IRD in a portfolio?

PortView shows IRD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Opus Genetics (IRD) Stock Analysis

NASDAQHealthcareBiotechnology

$4.36+13.71%

1-year price historyRange $1.27 – $5.75

52-week range$4.36

$1.22$5.81

What Opus Genetics does

Opus Genetics, Inc. is a clinical-stage biopharmaceutical company focused on ophthalmology. The company is dedicated to discovering and commercializing innovative therapies to address significant unmet medical needs in patients suffering from refractive and retinal eye disorders. Its portfolio includes Phentolamine Ophthalmic Solution, currently used to reverse pharmacologically induced mydriasis (pupil dilation). This solution is also advancing through Phase III clinical trials for the treatment of presbyopia and impaired vision in dim light or at night. A leading candidate in its retinal pipeline is APX3330, a small-molecule inhibitor targeting the reduction oxidation effector factor-1 protein. APX3330 has successfully completed Phase II clinical trials for diabetic retinopathy. Furthermore, Opus Genetics is developing APX2009 and APX2014, two preclinical product candidates also aimed at various retinal indications. Originally founded in 2018 as Ocuphire Pharma, Inc., the company maintains its headquarters in Farmington Hills, Michigan.

Key metrics

Market cap

$359.57M

P/E (TTM)

-3.40

EPS (TTM)

$-1.28

Beta

0.58

Dividend yield

0.00%

Revenue / share

$0.10

50-day avg

$3.72

200-day avg

$3.65

52-week high

$5.81

52-week low

$1.22

CEO

George Magrath

ETFs linked to IRD

Broad-market and Healthcare sector ETFs an investor holding Opus Genetics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how IRD fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze IRD in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Opus Genetics?: Opus Genetics trades under the ticker IRD on NASDAQ.
Which exchange is IRD listed on?: IRD is listed on NASDAQ.
What sector does Opus Genetics operate in?: Opus Genetics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze IRD in a portfolio?: PortView shows IRD's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.